42 tracked 13F filers disclose a position in LPCN as of the latest SEC 13F filings, a combined $17.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | $4.1M | 509K | ▲+155% Added · +309K sh | Q1 2026 | |
| 2 | Squadron Capital Management LLC | $3.6M | 450K | ▼−15% Reduced · −80K sh | Q1 2026 | |
| 3 | Eversept Partners, LP | $755K | 295K | —Held | Q2 2026 | |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $1.6M | 201K | →First observed position No prior filed position | Q1 2026 | |
| 5 | STEMPOINT CAPITAL LP | $1.3M | 160K | ▲New +160K sh | Q1 2026 | |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | $1.1M | 140K | ▲+156% Added · +86K sh | Q1 2026 | |
| 7 | BlackRock, Inc. | $713K | 89K | —Held | Q1 2026 | |
| 8 | CITADEL ADVISORS LLC | $208K | 81K | ▲+179% Added · +52K sh | Q2 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $191K | 74K | ▲+18% Added · +11K sh | Q2 2026 | |
| 10 | Exome Asset Management LLC | $486K | 61K | ▲New +61K sh | Q1 2026 | |
| 11 | DIADEMA PARTNERS LP | $400K | 50K | ▼−81% Reduced · −211K sh | Q1 2026 | |
| 12 | J. Goldman & Co LP | $337K | 42K | ▲New +42K sh | Q1 2026 | |
| 13 | RENAISSANCE TECHNOLOGIES LLC | $308K | 38K | ▲+2.9% Added · +1K sh | Q1 2026 | |
| 14 | TWO SIGMA INVESTMENTS, LP | $270K | 34K | ▲New +34K sh | Q1 2026 | |
| 15 | VANGUARD FIDUCIARY TRUST CO | $259K | 32K | →First observed position No prior filed position | Q1 2026 | |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | $199K | 25K | ▼~0% Reduced · −1 sh | Q1 2026 | |
| 17 | ADAR1 Capital Management, LLC | $185K | 23K | ▲New +23K sh | Q1 2026 | |
| 18 | STATE STREET CORP | $57K | 22K | —Held | Q2 2026 | |
| 19 | JANE STREET GROUP, LLC | $160K | 20K | ▲+89% Added · +9K sh | Q1 2026 | |
| 20 | DIMENSIONAL FUND ADVISORS LP | $153K | 19K | ▲+58% Added · +7K sh | Q1 2026 | |
| 21 | XTX Topco Ltd | $143K | 18K | ▲New +18K sh | Q1 2026 | |
| 22 | Birchview Capital, LP | $43K | 17K | ▼−85% Reduced · −95K sh | Q2 2026 | |
| 23 | NORTHERN TRUST CORP | $104K | 13K | ▼−0.9% Reduced · −118 sh | Q1 2026 | |
| 24 | PRELUDE CAPITAL MANAGEMENT, LLC | $101K | 13K | ▲New +13K sh | Q1 2026 | |
| 25 | AMERIPRISE FINANCIAL INC | $91K | 11K | ▼−29% Reduced · −5K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 9 funds opened a new position in LPCN and 4 added to an existing one, while 2 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 17 funds | $492.6M |
| BOSTON SCIENTIFIC CORPBSX | 15 funds | $1.1B |
| IONIS PHARMACEUTICALS INCIONS | 15 funds | $650.3M |
| GILEAD SCIENCES INCGILD | 14 funds | $896.2M |
| BRISTOL-MYERS SQUIBB COBMY | 14 funds | $883.0M |
| DANAHER CORPDHR | 14 funds | $706.1M |
| NOVO-NORDISK A/S-SPONS ADRNVO | 14 funds | $474.1M |
| INSMED INCINSM | 14 funds | $431.5M |
| CYTOKINETICS INCCYTK | 14 funds | $181.3M |
| VERA THERAPEUTICS INCVERA | 14 funds | $160.8M |
| INVIVYD INCIVVD | 14 funds | $20.1M |
| NVIDIA CORPNVDA | 13 funds | $6.5B |
Ranked by how many of LPCN's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Higuchi John W. | Director | Buy (P) | 40K | $81K |
| Apr 6, 2026 | Higuchi John W. | Director | Buy (P) | 123K | $252K |
| Apr 6, 2026 | Patel Mahesh V. | Chief Executive Officer, Director | Buy (P) | 25K | $51K |
| Apr 2, 2026 | Patel Mahesh V. | Chief Executive Officer, Director | Buy (P) | 25K | $51K |
| May 25, 2023 | Patel Mahesh V. | CEO and President, Director | Buy (P) | 9K | $44K |
| Mar 24, 2023 | Patel Mahesh V. | CEO and President, Director | Buy (P) | 150K | $48K |
| Mar 20, 2023 | Ono Richard Dana | Director | Buy (P) | 4K | $1K |
| Mar 17, 2023 | Patel Mahesh V. | CEO and President, Director | Buy (P) | 50K | $17K |
| Nov 22, 2022 | Papapetropoulos Spyros | Director | Buy (P) | 22K | $10K |
| Nov 14, 2022 | Patel Mahesh V. | CEO and President, Director | Buy (P) | 75K | $29K |
| Sep 27, 2022 | Patel Mahesh V. | CEO and President, Director | Buy (P) | 100K | $41K |
| May 17, 2022 | Fogarty Krista | Principal Accounting Officer | Buy (P) | 13K | $11K |
Connected entities for LPCN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/LPCN/capital-change-brief"
Use Arkolith's capital_change_brief for LPCN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for LPCN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.